Loading
A phase 2 trial of Glucarpidase, Methotrexate and Leucovorin in Osteosarcoma, run by University College, London, recorded as terminated on the registry.
Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays? is a phase 2 interventional study registered as NCT02022358 by University College, London, with 34 participants recorded, started 2007-07 and due to reach its primary completion in 2015-06. Interventions recorded: Glucarpidase, Methotrexate, Folinic Acid. Conditions recorded: Osteosarcoma, Spindle Cell Sarcoma of Bone.
Linked to the drug Glucarpidase because the registry names it among its interventions and Osteosarcoma among its conditions. Registry record only: no result has been read by an editor.
Shares Glucarpidase, Leucovorin (folinic acid), Osteosarcoma and the tag pipeline.
Shares Glucarpidase and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Leucovorin (folinic acid) and the tag pipeline.
Shares Leucovorin (folinic acid) and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.
Shares Osteosarcoma and the tag pipeline.